Metropolis Healthcare (NSE:METROPOLIS, BOM:542650) has incorporated a wholly-owned subsidiary named Metropolis Clinical Pathology, according to a Wednesday filing to the stock exchanges.
The new subsidiary aims to provide all kinds of diagnostic services, the filing said.
Price (INR): ₹1988.90, Change: ₹-25, Percent Change: -1.23%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。